Serum levels of olanzapine in a non-fatal overdose

Journal of Analytical Toxicology

Volumn 31, Issue 2, 2007, Pages 119-121

  Lennestål, Roland ^a   Asplund, Cay ^a   Nilsson, Mats ^a   Lakso, Hans Åke ^a   Mjörndal, Tom ^a   Hägg, Staffan ^b  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; CREATINE KINASE; DECANOIC ACID; LACTATE DEHYDROGENASE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE;

ADULT; ARTICLE; BLOOD SAMPLING; CASE REPORT; CLINICAL FEATURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG ELIMINATION; DRUG HALF LIFE; FECES INCONTINENCE; HUMAN; LIVER DISEASE; MALE; PALLOR; PARANOID SCHIZOPHRENIA; SEIZURE; URINE INCONTINENCE; VITAL SIGN; VOMITING;

EID: 34147092083     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/31.2.119     Document Type: Article

References (21)

1. B. Fulton and K.L. Goa. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses. Drugs 53(2): 281-298 (1997).
2. S. Palenzona, P.J. Meier, H. Kupferschmidt, and C. Rauber-Luethy. The clinical picture of olanzapine poisoning with special reference to fluctuating mental status. J. Toxicol. Clin. Toxicol. 42(1): 27-32 (2004).
3. P. Chue and P. Singer. A review of olanzapine-associated toxicity and fatality in overdose. J. Psychiatry Neurosci. 28(4): 253-261 (2003).
4. A. Trenton, G. Currier, and F. Zwemer. Fatalities associated with therapeutic use and overdose of atypical antipsychotics. CNS Drugs 17(5): 307-324 (2003).
5. J.E. Gerber and B. Cawthon. Overdose and death with olanzapine: two case reports. Am. J. Forensic Med. Pathol. 21(3): 249-251 (2000).
6. B.G. Stephens, D.E. Coleman, and R.C. Baselt. Olanzapine-related fatality. J. Forensic Sci. 43(6): 1252-1253 (1998).
7. A.A. Elian. Fatal overdose of olanzapine. Forensic Sci. Int. 91(3): 231-235 (1998).
8. M.D. Robertson and M.M. McMullin. Olanzapine concentrations in clinical serum and postmortem blood specimens - when does therapeutic become toxic? J. Forensic Sci. 45(2): 418-421 (2000).
9. L. Yip, R.C. Dart, and K. Graham. Olanzapine toxicity in a toddler. Pediatrics 102(6): 1494 (1998).
10. G. Catalano, D.S. Cooper, M.C. Catalano, and A.S. Butera. Olanzapine overdose in an 18-month-old child. J. Child Adolesc. Psychopharmacol. 9(4): 267-271 (1999).
11. M.M. Bonin and K.K. Burkhart. Olanzapine overdose in a 1-year-old male. Pediatr. Emerg. Care 15(4): 266-267 (1999).
12. S. Kochhar, J.N. Nwokike, B. Jankowitz, E.H. Sholevar, T. Abed, and D.A. Baron. Olanzapine overdose: a pediatric case report. J. Child Adolesc. Psychopharmacol. 12(4): 351-353 (2002).
13. F.M. Theisen, J. Grabarkiewicz, C. Fegbeutel, A. Hubner, C. Mehler-Wex, and H. Remschmidt. Olanzapine overdose in children and adolescents: two case reports and a review of the literature. J. Child Adolesc. Psychopharmacol. 15(6): 986-995 (2005).
14. L.G. Cohen, A. Fatalo, B.T. Thompson, G. Di Centes Bergeron, J.G. Flood, and P.R. Poupolo. Olanzapine overdose with serum concentrations. Ann. Emerg. Med. 34: 275-278 (1999).
15. J. Fogel and J.E. Diaz. Olanzapine overdose. Ann. Emerg. Med. 32: 275-276 (1998).
16. G.F. O'Malley, S. Seifert, K. Heard, F. Daly, and R.C. Dart. Olanzapine overdose mimicking opioid intoxication. Ann. Emerg. Med. 34: 279-281 (1999).
17. R.F. Bosch, A. Baumbach, M. Bitzer, and C.M. Erley. Intoxication with olanzapine. Am. J. Psychiatry 157(2): 304-305 (2000).
18. S. Hagg, O. Spigset, H.A. Lakso, and R. Dahlqvist. Olanzapine disposition in humans is unrelated to CYP1A2 and CYP2D6 phenotypes. Eur. J. Clin. Pharmacol. 57(6-7): 493-497 (2001).
19. K.L. Shirley, Y.Y. Hon, S.R. Penzak, Y.W. Lam, V. Spratlin, and M.W. Jann. Correlation of cytochrome P450 (CYP) 1A2 activity using caffeine phenotyping and olanzapine disposition in healthy volunteers. Neuropsychopharmacology 28(5): 961-966 (2003).
20. J.A. Carrillo, A.G. Herraiz, S.I. Ramos, G. Gervasini, S. Vizcaino, and J. Benitez. Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine. J. Clin. Psychopharmacol. 23(2): 119-127 (2003).
21. F. Sjokvist. FASS interaction. The Swedish Association of the Pharmaceutical Industry (LIF), 2006.